100 related articles for article (PubMed ID: 26398221)
1. Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies.
Fujimori T; Kato K; Fujihara S; Iwama H; Yamashita T; Kobayashi K; Kamada H; Morishita A; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2015 Dec; 34(6):2987-96. PubMed ID: 26398221
[TBL] [Abstract][Full Text] [Related]
2. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2014 Jul; 45(1):322-32. PubMed ID: 24806290
[TBL] [Abstract][Full Text] [Related]
3. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
Fujihara S; Kato K; Morishita A; Iwama H; Nishioka T; Chiyo T; Nishiyama N; Miyoshi H; Kobayashi M; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Int J Oncol; 2015 May; 46(5):2172-80. PubMed ID: 25709052
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
[TBL] [Abstract][Full Text] [Related]
6. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest.
Yamashita T; Kato K; Fujihara S; Iwama H; Morishita A; Yamana H; Kobayashi K; Kamada H; Chiyo T; Kobara H; Tsutsui K; Okano K; Suzuki Y; Masaki T
Anticancer Drugs; 2020 Mar; 31(3):231-240. PubMed ID: 31815765
[TBL] [Abstract][Full Text] [Related]
7. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of metformin in esophageal cancer: in vitro study.
Kobayashi M; Kato K; Iwama H; Fujihara S; Nishiyama N; Mimura S; Toyota Y; Nomura T; Nomura K; Tani J; Miyoshi H; Kobara H; Mori H; Murao K; Masaki T
Int J Oncol; 2013 Feb; 42(2):517-24. PubMed ID: 23229592
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma.
Chiyo T; Kato K; Iwama H; Fujihara S; Fujita K; Tadokoro T; Ohura K; Samukawa E; Yamana Y; Kobayashi N; Matsunaga T; Nishiyama N; Ayaki M; Yachida T; Morishita A; Kobara H; Mori H; Masaki T
Int J Oncol; 2017 Jun; 50(6):2145-2153. PubMed ID: 28440424
[TBL] [Abstract][Full Text] [Related]
10. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.
Kato K; Gong J; Iwama H; Kitanaka A; Tani J; Miyoshi H; Nomura K; Mimura S; Kobayashi M; Aritomo Y; Kobara H; Mori H; Himoto T; Okano K; Suzuki Y; Murao K; Masaki T
Mol Cancer Ther; 2012 Mar; 11(3):549-60. PubMed ID: 22222629
[TBL] [Abstract][Full Text] [Related]
11. Metformin facilitates BG45‑induced apoptosis via an anti‑Warburg effect in cholangiocarcinoma cells.
Tang D; Xu L; Zhang M; Dorfman RG; Pan Y; Zhou Q; Zhou L; Wang Y; Li Y; Yin Y; Wang L; Zou X
Oncol Rep; 2018 Apr; 39(4):1957-1965. PubMed ID: 29484415
[TBL] [Abstract][Full Text] [Related]
12. Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.
Zhu HQ; Ma JB; Song X; Gao HJ; Ma CQ; Chang H; Li HG; Liu FF; Lu J; Zhou X
Oncol Rep; 2016 Dec; 36(6):3488-3496. PubMed ID: 27779693
[TBL] [Abstract][Full Text] [Related]
13. Aspirin inhibits cholangiocarcinoma cell proliferation via cell cycle arrest in vitro and in vivo.
Shi T; Gong J; Fujita K; Nishiyama N; Iwama H; Liu S; Nakahara M; Yoneyama H; Morishita A; Nonura T; Kobara H; Okano K; Suzuki Y; Masaki T
Int J Oncol; 2021 Feb; 58(2):199-210. PubMed ID: 33491760
[TBL] [Abstract][Full Text] [Related]
14. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
Kuriyama S; Hitomi M; Yoshiji H; Nonomura T; Tsujimoto T; Mitoro A; Akahane T; Ogawa M; Nakai S; Deguchi A; Masaki T; Uchida N
Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434
[TBL] [Abstract][Full Text] [Related]
15. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2013 Dec; ():. PubMed ID: 24378856
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma.
Jiang X; Ma N; Wang D; Li F; He R; Li D; Zhao R; Zhou Q; Wang Y; Zhang F; Wan M; Kang P; Gao X; Cui Y
Oncotarget; 2015 Feb; 6(5):3178-94. PubMed ID: 25605008
[TBL] [Abstract][Full Text] [Related]
17. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study.
Li S; Han Z; Ma Y; Song R; Pei T; Zheng T; Wang J; Xu D; Fang X; Jiang H; Liu L
Oncol Rep; 2014 Jan; 31(1):145-52. PubMed ID: 24247752
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines.
Ling S; Feng T; Ke Q; Fan N; Li L; Li Z; Dong C; Wang C; Xu F; Li Y; Wang L
Oncol Rep; 2014 Jun; 31(6):2611-8. PubMed ID: 24788596
[TBL] [Abstract][Full Text] [Related]
19. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.
Chen HP; Shieh JJ; Chang CC; Chen TT; Lin JT; Wu MS; Lin JH; Wu CY
Gut; 2013 Apr; 62(4):606-15. PubMed ID: 22773548
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin on retinoblastoma growth in vitro and in vivo.
Brodowska K; Theodoropoulou S; Meyer Zu Hörste M; Paschalis EI; Takeuchi K; Scott G; Ramsey DJ; Kiernan E; Hoang M; Cichy J; Miller JW; Gragoudas ES; Vavvas DG
Int J Oncol; 2014 Dec; 45(6):2311-24. PubMed ID: 25215935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
